The agreement provides access for prescribed patients to Lilly's obesity medicines self-pay pricing starting at $149 per month without leaving the platform.
News|Articles|September 1, 2026
6 Ways Lab Data Can Improve Clinical Trials
Author(s)Quest Diagnostics
Advertisement
Discover how Quest Diagnostics’ comprehensive lab data can elevate your clinical trials. Our latest white paper, "6 Ways Lab Data Can Improve Clinical Trials," explores the power of real-world data at every stage of the trial process.
Advertisement
Related to this article
Brox.AI's co-founder and CEO on why telling an AI to pretend to be a doctor isn’t the same as cloning one — and why that distinction matters for pharma.
Brox.AI’s Hamish Brocklebank on three levels of digital clone use cases — from HCP content testing and GLP-1 price sensitivity modeling to simulating physician adoption after FDA approval.
Brox.AI’s Hamish Brocklebank on the three approaches to digital twins in pharma — and why only one-to-one clones of real individuals deliver true accuracy.
Advertisement
Advertisement
Trending on PharmExec
1
The US Drug-Pricing Reset: Competing on Net Value
2
Novo Terminates Research Collaboration With Korro Bio
3
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro
4
Hims & Hers Partners with Eli Lilly to Sell Obesity Medicines
5